MX2013013906A - Vacunas combinadas para prevencion de infecciones por virus porcino. - Google Patents

Vacunas combinadas para prevencion de infecciones por virus porcino.

Info

Publication number
MX2013013906A
MX2013013906A MX2013013906A MX2013013906A MX2013013906A MX 2013013906 A MX2013013906 A MX 2013013906A MX 2013013906 A MX2013013906 A MX 2013013906A MX 2013013906 A MX2013013906 A MX 2013013906A MX 2013013906 A MX2013013906 A MX 2013013906A
Authority
MX
Mexico
Prior art keywords
vaccine
porcine
prevention
virus infections
combined vaccines
Prior art date
Application number
MX2013013906A
Other languages
English (en)
Other versions
MX347210B (es
Inventor
Hua Wu
Yanliang He
Mingqi Xia
Original Assignee
Sinovet Beijing Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201110140951.5A external-priority patent/CN102727883B/zh
Priority claimed from CN201110331206.9A external-priority patent/CN102727884B/zh
Priority claimed from CN201110331159.8A external-priority patent/CN102727882B/zh
Application filed by Sinovet Beijing Biotechnology Co Ltd filed Critical Sinovet Beijing Biotechnology Co Ltd
Publication of MX2013013906A publication Critical patent/MX2013013906A/es
Publication of MX347210B publication Critical patent/MX347210B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/187—Hog cholera virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

La presente descripción proporciona composiciones de vacuna que comprenden una vacuna para PRRSV y una segunda vacuna porcina, las cuales están sustancialmente libres de inmuno-inhibición una en contra de la otra. La segunda vacuna para el virus porcino puede ser CSFV y/o PRV. También se proporcionan los métodos de preparación para las vacunas y las formulaciones. Las composiciones de vacuna proporcionadas en la presente confieren inmunidad protectora a los cerdos en contra del Síndrome Respiratorio y Reproductivo Porcino, fiebre porcina clásica, y/o seudorrabia.
MX2013013906A 2011-05-27 2012-05-25 Vacunas combinadas para prevención de infecciones por virus porcino. MX347210B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201110140951.5A CN102727883B (zh) 2011-05-27 2011-05-27 猪繁殖与呼吸综合征与猪瘟二联疫苗及其用途
CN201110331206.9A CN102727884B (zh) 2011-10-27 2011-10-27 猪繁殖与呼吸综合征、伪狂犬病二联活疫苗及其制备方法
CN201110331159.8A CN102727882B (zh) 2011-10-27 2011-10-27 猪繁殖与呼吸综合征、猪瘟、伪狂犬病的三联活疫苗及其制备方法
PCT/CN2012/076125 WO2012163258A1 (en) 2011-05-27 2012-05-25 Combined vaccines for prevention of porcine virus infections

Publications (2)

Publication Number Publication Date
MX2013013906A true MX2013013906A (es) 2014-04-14
MX347210B MX347210B (es) 2017-04-19

Family

ID=47258374

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013013906A MX347210B (es) 2011-05-27 2012-05-25 Vacunas combinadas para prevención de infecciones por virus porcino.

Country Status (9)

Country Link
US (1) US9592286B2 (es)
JP (1) JP6096176B2 (es)
KR (1) KR20140036262A (es)
BR (1) BR112013030321A2 (es)
CA (1) CA2837125A1 (es)
MX (1) MX347210B (es)
RU (1) RU2628313C2 (es)
TW (1) TWI579297B (es)
WO (1) WO2012163258A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013030321A2 (pt) * 2011-05-27 2017-07-11 Sinovet Beijing Biotechnology Co Ltd composição de vacina, método para preparar a composição de vacina, uso da composição de vacina, método para imunizar um porco, cepa de vacina contra csfv e uso de uma célula no cultivo de uma cepa de vacina contra csfv.
US9457073B2 (en) * 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
WO2015048115A1 (en) * 2013-09-25 2015-04-02 Zoetis Llc Pcv2b divergent vaccine composition and methods of use
RU2683544C1 (ru) * 2013-12-12 2019-03-28 Интервет Интернэшнл Б.В. Иммортализованный макрофаг
CN104250640A (zh) * 2014-08-22 2014-12-31 普莱柯生物工程股份有限公司 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用
CN111560355A (zh) * 2015-03-20 2020-08-21 普莱柯生物工程股份有限公司 一种猪伪狂犬病病毒致弱方法、及其致弱的病毒株、疫苗组合物和应用
KR101642727B1 (ko) * 2015-12-31 2016-07-27 대한민국 약독화된 돼지열병 바이러스 생마커백신주 및 이를 이용한 경구투여용 백신 조성물
US10344293B2 (en) * 2016-05-12 2019-07-09 Bio Applications Inc. Vaccine composition for classical swine fever from plant and manufacturing method thereof
CN107299078B (zh) * 2017-07-27 2020-06-05 郑州爱科生物科技有限公司 一株适应全悬浮培养的猫肾细胞系f-81 s及其应用
CN107653230A (zh) * 2017-08-31 2018-02-02 浙江大学 一种ⅱ型伪狂犬病毒毒株及其应用
CN107815441B (zh) * 2017-08-31 2020-05-12 浙江大学 一种ⅱ型伪狂犬病毒减毒株及其制备方法和应用
CN109735564B (zh) * 2018-12-26 2023-04-21 河南农业大学 一种猪伪狂犬病病毒变异株HN-QYY-gE-/TK-的构建方法和应用
CN111057145B (zh) * 2019-11-22 2021-10-08 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 猪繁殖与呼吸综合征病毒Nsp2蛋白纳米抗体及其应用
CN111875678B (zh) * 2020-07-07 2021-10-08 华南农业大学 表达猪繁殖与呼吸综合征病毒gp3/gp5/m基因的重组伪狂犬病毒、构建方法和应用
CN113321712B (zh) * 2021-07-20 2023-02-24 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一组猪繁殖与呼吸综合征病毒的抗原多肽及其应用
CN116064557A (zh) * 2022-09-15 2023-05-05 华中农业大学 激活猪的ogfod2基因表达的制剂在制备猪抗伪狂犬病毒感染药物中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751224B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
ATE199022T1 (de) 1996-10-09 2001-02-15 Akzo Nobel Nv Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des sweins (prrsv)
CN1283788C (zh) 2003-06-02 2006-11-08 中国农业科学院哈尔滨兽医研究所 表达猪繁殖与呼吸综合征病毒的重组伪狂犬病毒及应用
NZ561848A (en) 2005-02-25 2010-02-26 Pfizer Prod Inc N protein mutants of porcine reproductive and respiratory syndrome virus
PT1904631E (pt) * 2005-06-24 2012-07-16 Univ Minnesota Vírus srrp, clones infecciosos, os seus mutantes e processos de utilização
EP1792996A1 (en) 2005-12-01 2007-06-06 Consejo Superior de Investigaciones Cientificas Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV)
CN101307305B (zh) 2008-04-30 2010-06-16 中国动物疫病预防控制中心 一种猪繁殖与呼吸综合征病毒弱毒株及免疫原性物质和疫苗
CN101280292B (zh) 2008-05-13 2010-10-13 中国农业科学院哈尔滨兽医研究所 猪繁殖与呼吸综合征病毒强毒株、其弱毒疫苗株及其应用
KR20100121288A (ko) 2009-05-08 2010-11-17 대한민국(관리부서 : 농림수산식품부 국립수의과학검역원) 유전자재조합 돼지열병 백신바이러스 Ｆｌｃ―ＬＯＭ―ＢＥｒｎｓ ｖｉｒｕｓ 및 이의 제조방법
KR20100121289A (ko) 2009-05-08 2010-11-17 대한민국(관리부서 : 농림수산식품부 국립수의과학검역원) 유전자재조합 돼지열병 백신바이러스 Ｆｌｃ―ＬＯＭ ｖｉｒｕｓ 및 이의 제조방법
CN101603035B (zh) 2009-05-18 2011-06-08 中国兽医药品监察所 猪繁殖与呼吸综合征病毒嵌合重组疫苗株及其生产活疫苗的方法
CN101633909B (zh) 2009-08-13 2012-05-09 华威特（北京）生物科技有限公司 预防猪感染猪繁殖与呼吸综合征的减毒活疫苗
CN101991849A (zh) 2009-08-18 2011-03-30 上海科立特农科（集团）有限公司 一种猪伪狂犬病灭活疫苗的制备方法
CN101690808A (zh) 2009-10-14 2010-04-07 广东永顺生物制药有限公司 猪瘟、伪狂犬病二联活疫苗的制备方法及其制品
US20110150770A1 (en) * 2009-12-18 2011-06-23 Boehringer Ingelheim Vetmedica, Inc. Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
CN101879311A (zh) * 2010-06-28 2010-11-10 武华 猪瘟活疫苗的制备方法及其产品
BR112013030321A2 (pt) * 2011-05-27 2017-07-11 Sinovet Beijing Biotechnology Co Ltd composição de vacina, método para preparar a composição de vacina, uso da composição de vacina, método para imunizar um porco, cepa de vacina contra csfv e uso de uma célula no cultivo de uma cepa de vacina contra csfv.

Also Published As

Publication number Publication date
JP6096176B2 (ja) 2017-03-15
JP2014516041A (ja) 2014-07-07
TW201300406A (zh) 2013-01-01
RU2628313C2 (ru) 2017-08-15
MX347210B (es) 2017-04-19
WO2012163258A1 (en) 2012-12-06
CA2837125A1 (en) 2012-12-06
TWI579297B (zh) 2017-04-21
RU2013158322A (ru) 2015-07-10
KR20140036262A (ko) 2014-03-25
BR112013030321A2 (pt) 2017-07-11
US9592286B2 (en) 2017-03-14
US20140093535A1 (en) 2014-04-03

Similar Documents

Publication Publication Date Title
MX2013013906A (es) Vacunas combinadas para prevencion de infecciones por virus porcino.
HK1201197A1 (en) Effective vaccination against porcine reproductive and respiratory syndrome (prrs) virus prior to weaning (prrs)
MX2016003419A (es) Metodos y composiciones para sindrome respiratorio coronavirus de oriente medio (mers-cov) inmunogenico.
MX2012009581A (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
EA202090699A2 (ru) Композиции, содержащие буфер, вакцины, которые содержат композиции, содержащие буфер, и пути их применения
MX2015010305A (es) Vacuna de combinacion para virus sincitial respiratorio e influenza.
MX366051B (es) Composiciones del virus del síndrome reproductor y respiratorio de porcino y sus usos.
MY189495A (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MX370715B (es) Vacuna de subunidades anti-mycoplasma spp.
NZ618158A (en) Compositions and methods for administration of vaccines against dengue virus
PH12019500989A1 (en) Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
WO2014150822A3 (en) Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
PH12018501368A1 (en) M hyo multivalent vaccine and uses thereof
MX2015007723A (es) PARVOVIRUS PORCINO 5ª, METODOS DE USO Y VACUNA.
MX347911B (es) Vacuna contra virus de diarrea viral de bovinos.
PH12015501721A1 (en) Porcine parvovirus 5b, methods of use and vaccine
PH12018501750A1 (en) Porcine reproductive and respiratory syndrome vaccine virus
EA201500140A1 (ru) Ослабленные вакцины от свиного гриппа и способы их получения и применения
WO2014074817A3 (en) Attenuated mannheimia haemolytica vaccines and methods of making and use
MX2015005112A (es) Composicion inmunogenica contra la aeromonas hydrophila.
WO2014167582A3 (en) Vaccine composition for prophylaxis in ruminants
WO2016012406A3 (en) Attenuated strain of prrs and potential use in immunising preparations
MX350718B (es) Vacuna de rinitis equina.
PH12019550018A1 (en) Porcine reproductive and respiratory syndrome virus cdna clone and uses thereof
TH141504A (th) วัคซีนรวมสำหรับการป้องกันของการติดเชื้อไวรัสของสุกร (Combined Vaccines for Prevention of Porcine Virus Infections)

Legal Events

Date Code Title Description
FG Grant or registration